What's Happening?
Koya Medical, a medtech company focused on peripheral vascular health, will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. CEO Andy Doraiswamy will discuss the company's growth and the commercial momentum of its portfolio,
including the Dayspring® non-pneumatic compression treatment for chronic edema. The presentation will highlight Koya's progress in clinical research and its commitment to advancing patient-centered solutions in vascular health.
Why It's Important?
Koya Medical's participation in the Oppenheimer conference underscores its role as an emerging innovator in the medtech industry. By showcasing its advancements in vascular health solutions, Koya is positioning itself as a leader in addressing the needs of patients with venous and lymphatic diseases. The company's focus on scalable and evidence-based treatments aligns with the growing demand for modern healthcare solutions that improve patient outcomes and quality of life. This presentation could attract potential investors and partners, further supporting Koya's mission to redefine vascular health.
